Orchestra BioMed Holdings (OBIO) Return on Capital Employed (2022 - 2025)
Historic Return on Capital Employed for Orchestra BioMed Holdings (OBIO) over the last 4 years, with Q3 2025 value amounting to 1.42%.
- Orchestra BioMed Holdings' Return on Capital Employed fell 3700.0% to 1.42% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.42%, marking a year-over-year decrease of 3700.0%. This contributed to the annual value of 0.93% for FY2024, which is 3100.0% down from last year.
- Latest data reveals that Orchestra BioMed Holdings reported Return on Capital Employed of 1.42% as of Q3 2025, which was down 3700.0% from 2.1% recorded in Q2 2025.
- In the past 5 years, Orchestra BioMed Holdings' Return on Capital Employed registered a high of 0.37% during Q2 2023, and its lowest value of 2.1% during Q2 2025.
- Its 4-year average for Return on Capital Employed is 0.91%, with a median of 0.81% in 2024.
- Per our database at Business Quant, Orchestra BioMed Holdings' Return on Capital Employed crashed by -300bps in 2023 and then tumbled by -11800bps in 2025.
- Over the past 4 years, Orchestra BioMed Holdings' Return on Capital Employed (Quarter) stood at 0.51% in 2022, then dropped by -6bps to 0.54% in 2023, then crashed by -98bps to 1.08% in 2024, then plummeted by -31bps to 1.42% in 2025.
- Its Return on Capital Employed was 1.42% in Q3 2025, compared to 2.1% in Q2 2025 and 1.32% in Q1 2025.